Interactive explainers

The science of blood, made visual.

Interactive timelines that trace how treatment actually evolved — disease by disease, trial by trial. Each is built from primary literature, ClinicalTrials.gov, and FDA/EMA records, and written to be understood by patients and useful to clinicians.

Multiple Myeloma

Four Decades of Myeloma Therapy

From melphalan to CAR-T — the trials that turned a two-to-three-year prognosis into a disease many people live with for decades. Trace each approval and the survival curve that climbed with it.

Open the timeline CLL / SLL

Four Decades of CLL/SLL Therapy

The shift from chemotherapy to targeted, fixed-duration, chemo-free care — including the del(17p)/TP53 thread that reshaped how we treat high-risk disease.

Open the landscape Anticoagulation

The Anticoagulation Arc

A century of trading clotting risk against bleeding — from heparin and warfarin through the DOAC era to the Factor XI inhibitors designed to separate thrombosis from hemostasis.

Open the timeline

How these are built. Every timeline is sourced to primary literature (NEJM, Lancet, JCO, Blood, Nature Medicine), the ClinicalTrials.gov registry, and FDA/EMA approval records. The aim is to be rigorous enough for a colleague and clear enough for a patient — more explainers are on the way.